Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) Director James Healy acquired 969,480 shares of the company’s stock in a transaction dated Wednesday, October 28th. The shares were acquired at an average cost of $21.00 per share, with a total value of $20,359,080.00. Following the completion of the purchase, the director owned 2,815,707 shares in […]

City Holding Company (NASDAQ:CHCO – Get Free Report) Director Robert Fisher acquired 165 shares of the stock in a transaction on Friday, October 23rd. The shares were bought at an average price of $142.13 per share, for a total transaction of $23,451.45. Following the purchase, the director owned 47,877 shares in the company, valued at […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) Director Ramiro Sanchez purchased 3,600 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were purchased at an average cost of $27.35 per share, with a total value of $98,460.00. Following the completion of the purchase, the director owned 3,600 […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) Director John Maraganore acquired 9,411 shares of the business’s stock in a transaction that occurred on Thursday, October 22nd. The shares were acquired at an average cost of $26.45 per share, with a total value of $248,920.95. Following the completion of the transaction, the director directly owned […]